Sigma Advanced Systems Limited has successfully completed the divestment of its entire 36.52% equity stake in Switzerland-based Extrovis AG, generating $15 million (approximately ₹137.61 crores) as the company sharpens its focus on aerospace and defence operations. The transaction marks a significant milestone in the company's portfolio rationalization strategy.

Transaction Overview

The completed divestment represents Sigma's strategic exit from non-core pharmaceutical investments to concentrate resources on its core aerospace and defence business. The key transaction parameters are detailed below:

Strategic Portfolio Transformation

According to CEO Sunil Kalidindi, the Extrovis divestment is part of Sigma's deliberate strategy to become a pure-play aerospace and defence platform. The transaction provides enhanced financial flexibility to invest in manufacturing capabilities, pursue strategic acquisitions, and expand presence across global defence and aerospace supply chains.

The company has been actively building its international platform through strategic acquisitions. Sigma recently acquired Delhi-based AS Strategic, a defence and space-focused firm with established European operations through long-term joint ventures and exclusive service partnerships with leading global defence OEMs.

Recent Acquisitions and Expansion

Sigma's acquisition strategy includes two major transactions that strengthen its global positioning:

Order Book Growth

Alongside its acquisition strategy, Sigma has continued expanding its domestic order book. The company recently secured new orders worth approximately ₹100 crores from India's Ministry of Defence and associated Defence PSUs, demonstrating continued customer reliance for defence electronics and mission-critical systems.

The company indicated it will continue growth through organic expansion and targeted acquisitions, with multiple opportunities currently under evaluation. The Extrovis divestment proceeds will support this expansion strategy while maintaining focus on high-complexity, safety-critical components and systems across aerospace and defence sectors.

Sigma Advanced Systems Limited (formerly Megasoft Limited) has received regulatory fines totaling ₹9.67 lakh from both BSE and NSE for failing to maintain the minimum board composition requirements under SEBI Listing Regulations. The company disclosed this development through a regulatory filing dated February 28, 2026.

Regulatory Action Details

Both exchanges imposed identical penalties on the company for non-compliance with Regulation 17(1) of SEBI (LODR) Regulations, 2015. The fine structure breakdown is as follows:

The company received emails from both BSE Limited and National Stock Exchange of India Limited on February 27, 2026, formally notifying about the penalty imposition.

Compliance Violation Background

The regulatory breach occurred following the resignation of Mr. Krishna Yeachuri as Director, which reduced the board composition to five directors. This fell short of the minimum requirement of six directors as mandated under Regulation 17 of SEBI (LODR) Regulations, 2015.

The violation specifically pertained to board composition requirements, with the company acknowledging that it had "fallen short of One Director" from the prescribed minimum threshold.

Remedial Action Taken

To address the compliance gap, the company appointed Mr. Cheemarla Damodar Reddy as Additional Director (Non-Executive, Non-Independent) on the Board with effect from December 22, 2025. This appointment restored the board to the required minimum composition and brought the company back into compliance with Regulation 17 provisions.

Financial and Operational Impact

The company has assessed that the regulatory fine will have no material impact on its financial position or operational activities. In its disclosure, Sigma Advanced Systems stated: "There is no material impact on financials, operations or other activities of the Company."

The company confirmed it will pay the imposed fines to both exchanges in compliance with applicable SEBI listing regulations and circulars. The penalty represents a regulatory cost arising from the temporary board composition shortfall rather than any operational or business-related issues.